BioAlliance Pharma publishes its 2010 financial calendar

BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, has announced its financial calendar for 2010:
February 9, 2010 Publication of the annual revenue statement for 2009
March 3, 2010 Publication of the consolidated accounts for 2009
March 4, 2010 SFAF analyst meeting at the Company’s head office
April 1, 2010 Publication of the Company’s financial annual report and French “Document de Référence” for 2009
April 22, 2010 Annual General Meeting at the Company’s head office
April 22, 2010 Publication of the revenue statement for Q1 2010
July 22, 2010 Publication of the revenue statement for Q2 2010
August 25, 2010 Publication of the consolidated half-year accounts as of June 30 2010
August 26, 2010 SFAF analyst meeting at the Company’s head office
October 21, 2010 Publication of the revenue statement for Q3 2010
All financial press releases are published after stock market closing.
Along with other information on BioAlliance Pharma S.A., a regularly updated “Investors” section is available on the company’s website (www.onxeo.com).

091222EN_CalendrierFinancier2010